CMPX Compass Therapeutics Net earnings per share growth this year
Compass Therapeutics is integrating ESG principles into biopharmaceuticals, adhering to testing ethics and environmental sustainability. Compass Therapeutics is developing a synergistic environment for combined cancer immunotherapy. The GURU.Markets platform contains the 12-month earnings per share growth rates, where the -21.00 metric determines this level. Business stability relies on patent protection for antibodies, although ultimate resilience depends on clinical trial outcomes.
Analytical breakdowns and data insights for company Compass Therapeutics (CMPX)
- current quotes and average value forecast:
- market capitalization data:
- company book value details:
- debt and liquidity details:
Debt to Equity Ratio Compass Therapeutics|CMPX - Long-Term Debt to Equity|Current Liabilities to Capital compasstherapeutics.com|CMPX - Company Total Debt|Debt to Net Assets Compass Therapeutics Corp|CMPX - Company Long-Term Liabilities|Amount of Current Liabilities Compass Therapeutics|Intermediate Coverage Ratio compasstherapeutics.com
- net income and valuation ratios data:
CMPX - Net Profit|Expected Net Profit Compass Therapeutics|CMPX - Price to Earnings Ratio|Future Price to Earnings Multiple Compass Therapeutics Corp|CMPX - PEG Multiple|EV/EBITDA Multiple Compass Therapeutics Corp|CMPX - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Compass Therapeutics|CMPX - Net earnings per share for the last 12 months|Earnings per share growth in annualized terms for the last twelve months compasstherapeutics.com|CMPX - Earnings growth in current year|Expected earnings per share growth for next year Compass Therapeutics
Summary company analysis:CMPX (Compass Therapeutics Inc)
This indicator measures the year-over-year dynamics of net profit per share, reflecting the efficiency of business capitalization through changes in EPS. For Compass Therapeutics (CMPX), this annual EPS percentage change depends critically on clinical trial costs and FDA regulatory decisions, where any deviations from antibody forecasts instantly translate into earnings volatility.
Key competitors
IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year Immunocore PLC|Net earnings per share growth this year Janux Corp (JANX)|Earnings per share growth in current year Arcus Biosciences, Inc. (RCUS)|Net earnings per share growth this year zymeworks.com ZYME|Tango Therapeutics, Inc. - Net earnings per share growth this year|Earnings growth in current year Iovance Biotherapeutics Inc IOVA|IMTX - Earnings per share growth in current year|XNCR (Xencor Inc.) - Earnings per share growth this year|Replimune Group, Inc. (REPL) - Earnings per share growth in current year|Earnings per share growth rate in current year lyell.com (LYEL)|Net earnings per share growth this year IPHA|PYXS - Net earnings per share change in current year|Net earnings per share growth this year CGEN (Compugen Ltd.)|Net earnings per one share growth for the current year IOBT|Earnings growth in current year STRO (Sutro Biopharma, Inc.)|Earnings per share increase in current year INKT|Werewolf - Earnings growth in current year|Earnings per share growth rate in current year Immix Biopharma, Inc.|ALX Oncology (ALXO) - Earnings per share growth in current year|Cue Biopharma Inc. - Earnings per share increase in current year|PDSB (PDS Biotech) - Earnings growth in current year|Earnings growth in current year Sonnet BioTherapeutics Holdings Inc.|Earnings per share growth in current year MAIA Biotechnology, Inc. (MAIA)|LIMN: Earnings per share trend in current year|LAVA Therapeutics - Net earnings per share growth this year|NextCure Corporation (NXTC) - Earnings per share growth rate in current year|Leap Tx - Earnings growth in current year|Intensity Therapeutics (INTS) - Net earnings per share growth this year|senseibio.com (SNSE) - Earnings per share growth in current year|Earnings per share growth rate in current year Theriva Biologics Inc (TOVX)|Earnings per share growth in current year Gritstone bio Inc.|Net earnings per share growth this year Kineta Corp (KA)|Earnings per share growth in current year NexImmune, Inc. (NEXI)|TSBX: Earnings per share trend in current year|Earnings growth in current year VCNX (Vaccinex)|Earnings growth in current year Harpoon Therapeutics Inc HARP
